 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > AVANIR Pharmaceuticals
 |
AVANIR Pharmaceuticals |
 |
 |
 |
PROFILE |
 |
AVANIR Pharmaceuticals is one sore company. The firm makes docosanol cream, a treatment for oral herpes. AVANIR has a licensing agreement with GlaxoSmithKline for exclusive distribution of the product -- trade name Abreva -- in North America. The development-stage company is also working on several other products, including drugs to treat allergies and asthma by regulating the IgE antibody, as well as treatments for central nervous system disorders, high cholesterol, and inflammation. AVANIR set up a subsidiary, Xenerex Biosciences, to provide antibody generation services to other companies and to develop its own antibody-based treatments for various diseases.
COMPETITION |
 |
ICN Pharmaceuticals, Inc. (ICN)
Johnson & Johnson (JNJ)
Schering-Plough Corporation (SGP)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 10.30
1-Yr. Sales Growth: 10,200.0%
Employees: 30
Revenue per employee: $343,333.33
KEY PEOPLE |
 |
Gerald J. Yakatan
CEO
Gregory P. Hanson
CFO
CONTACT INFO |
 |
11388 Sorrento Valley Rd.
San Diego, CA 92121
US
Phone: 858-622-5200
Fax: 858-453-5845
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |